International Journal of Pharma and Bio Sciences
    ISSN 0975-6299

Int J Pharm Bio Sci Volume 15 Issue 1, January - March, Pages:1-9

Prevalence and Pattern of COVID-19 Infection Among Kidney Transplant Recipients: A Case-Control Study

Dr. Moturu Venkata Viswanath, Dr Varaprasada Rao Kaki, Dr Sirisha G and Dr NST. Tejaswi Karri

The COVID-19 pandemic has affected health care across the globe. Since the initiation of the pandemic, there have been significant changes in the approach toward kidney transplantation and the management of COVID-19 infection among transplant recipients. Data on the prevalence, risk factors, presentation, and management of kidney transplant subjects has been less, especially from India. Hence the current study was undertaken. The current study was done with the aim of knowing the prevalence and pattern of COVID-19 infection. The study was carried out in the Department of Nephrology at a tertiary care centre named NRI. Medical College, Mangalagiri, Andhra Pradesh, India on 100 renal transplant recipients. Male and female patients aged above 18 years. admitted to the nephrology department at NRI Medical College, who underwent renal transplantation previously, and who provided informed consent were taken as the source of study patients. This case-control study was done for 12 months from October 2021 to September 2022. All parameters were compared between cases and controls. Results showed that the prevalence of COVID-19 was 22%. There was a significant difference in the mean age, ESR, CRP levels, respiratory rate, oxygen saturation, and death rate between cases and controls. The mean duration of hospitalization and death rate were significantly higher among cases compared to controls. The need for admission and mechanical ventilation was also significantly higher among cases compared to controls. There was no significant difference in gender between cases and controls. Most of the cases had clinical symptoms like dyspnoea and dry cough. Most of the controls had myalgia and easy fatigability. The mean no of comorbidities was 3.4±0.9 and the mean no of comorbidities among controls was 1.8±1.1 Mean number of comorbidities among cases was significantly higher compared to controls. In conclusion, there was a significant difference in adverse outcomes like ICU admission, need for mechanical ventilation, and mortality between renal transplantation patients with COVID-19 and those without COVID-19.

Keywords: COVID-19, Kidney transplants, Prevalence and Pattern, Pandemic, Immunosuppression
Full HTML:
  1. COVID-19 Public Health Emergency of International Concern (PHEIC) Global research and innovation forum [internet]. [cited Jul 16 2023]. Available from:
  2. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. (PMC Free article). doi: 10.1001/jama.2020.1585, PMID 32031570, Google Scholar.
  3. Abrishami A, Samavat S, Behnam B, Arab-Ahmadi M, Nafar M, Sanei Taheri MS. Clinical course, imaging features, and outcomes of COVID-19 in kidney transplant recipients. Eur Urol. 2020;78(2):281-6. doi: 10.1016/j.eururo.2020.04.064, PMID 32409114.Ozturk S, Turgutalp K, Arici M, Odabas AR, Altiparmak MR, Aydin Z, et al. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey. Nephrol Dial Transplant. 2020;35(12):2083-95. doi: 10.1093/ndt/gfaa271, PMID 33275763.
  4. Zhu L, Gong N, Liu B, Lu X, Chen D, Chen S, et al. Coronavirus disease 2019 pneumonia in immunosuppressed renal transplant recipients: a summary of 10 confirmed cases in Wuhan China. Eur Urol. 2020;77(6):748-54. doi: 10.1016/j.eururo.2020.03.039, PMID 32317180.
  5. Guillen E, Pineiro GJ, Revuelta I, Rodriguez D, Bodro M, Moreno A et al. Case report of COVID-19 in a kidney transplant recipient: does immunosuppression alter the clinical presentation? Am J Transplant. 2020;20(7):1875-8. (PMC Free article). doi: 10.1111/ajt.15874, PMID 32198834, Google Scholar.
  6. Gandolfini I, Delsante M, Fiaccadori E, Zaza G, Manenti L, Degli Antoni A et al. COVID-19 in kidney transplant recipients. Am J Transplant. 2020;20(7):1941-3. (PMC Free article). doi: 10.1111/ajt.15891, PMID 32233067, Google Scholar.
  7. Seminari E, Colaneri M, Sambo M, Gallazzi I, Di Matteo A, Roda S et al. SARS Cov2 infection in a renal transplanted patient. A case reports. Am J Transplant. 2020;20(7):1882-4. (PMC Free article). doi: 10.1111/ajt.15902, PMID 32243672, Google Scholar.
  8. Chen S, Yin Q, Shi H, Du D, Chang S, Ni L et al. A familial cluster, including a kidney transplant recipient, of coronavirus disease 2019 (COVID-19) in Wuhan, China. Am J Transplant. 2020;20(7):1869-74. (PMC Free article). doi: 10.1111/ajt.15903, PMID 32243690, Google Scholar.
  9. Wang J, Li X, Cao G, Wu X, Wang Z, Yan T. COVID-19 in a kidney transplant patient. Eur Urol. 2020;77(6):769-70. (PMC Free article). doi: 10.1016/j.eururo.2020.03.036, PMID 32273181, Google Scholar.
  10. Bartiromo M, Borchi B, Botta A, Bagalà A, Lugli G, Tilli M et al. Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19) [published online ahead of print Apr 12, 2020]. Transpl Infect Dis. 2020;22(4):e13286. doi: 10.1111/tid.13286. (PMC Free article). PMID 32279418.
  11. Marx D, Moulin B, Fafi-Kremer S, Benotmane I, Gautier G, Perrin P et al. First case of COVID-19 in a kidney transplant recipient treated with Belatacept. Am J Transplant. 2020;20(7):1944-6. (PMC Free article). doi: 10.1111/ajt.15919, PMID 32282977, Google Scholar.
  12. Arpali E, Akyollu B, Yelken B, Tekin S, Turkmen A, Kocak B. Case report: a kidney transplant patient with mild COVID-19 [published online ahead of print Apr 16, 2020]. Transpl Infect Dis. 2020;22(4):e13296. doi: 10.1111/tid.13296. (PMC Free article). PMID 32301198.
  13. Bussalino E, De MA, Russo R, Paoletti E. Immunosuppressive therapy maintenance in a kidney transplant recipient SARS-CoV-2 pneumonia: a case report. Am J Transplant. 2020;20:1922-4. (PMC Free article). PMID .
  14. Meshram HS, Kute VB, Patel HV, Hegde U, Das P, Sil K, et al. Is Early COVID-19 in kidney transplant recipients concerning enough to halt transplantation? A multicenter comparative analysis from India. Transplant Proc. 2021;53(8):2468-75. doi: 10.1016/j.transproceed.2021.08.034, PMID 34556343.
  15. [cited Jul 16 2023]. Available from:
  16. Karuthu S, Blumberg EA. Common infections in kidney transplant recipients. Clin J Am Soc Nephrol. 2012;7(12):2058-70. doi: 10.2215/CJN.04410512, PMID 22977217, Google Scholar.
  17. Aulagnon F, Scemla A, DeWolf S, Legendre C, Zuber J. Diarrhea after kidney transplantation: a new look at a frequent symptom. Transplantation. 2014;98(8):806-16. doi: 10.1097/TP.0000000000000335, PMID 25073040, Google Scholar.
  18. Michaels MG, La Hoz RM, Danziger-Isakov L, Blumberg EA, Kumar D, Green M et al. Coronavirus disease 2019: implications of emerging infections for transplantation. Am J Transplant. 2020;20(7):1768-72. (PMC Free article). doi: 10.1111/ajt.15832, PMID 32090448, Google Scholar.
  19. Devresse A, Belkhir L, Vo B, Ghaye B, Scohy A, Kabamba B et al. COVID-19 infection in kidney transplant recipients: A single-center case series of 22 cases from Belgium. Kidney Med. 2020 Jun 15;2(4):459-66. doi: 10.1016/j.xkme.2020.06.001, PMID 32775986, PMCID PMC7295531.
  20. Alberici F, Delbarba E, Manenti C. Management of patients on dialysis and with kidney transplant during SARS-COV-2 (COVID-19) pandemic in Brescia, Italy. Kidney Int Rep. 2020;5:580-5. (PMC Free article). PMID , Google Scholar.
  21. Francophone S, Pr F, Epailly E, Sebbag L. Nubret K. Prise en charge de l’infection due au SARS-CoV- chez les patients adultes transplantés d’organe solide [internet]. [cited Jul 16 2023]. Available from:
  22. [cited Jul 16 2023]. Available from:
  23. Monfared A, Akhondzadeh L, Mousazadeh M, Jafari A, Khosravi M, Lebadi M et al. COVID-19 in renal transplant recipients and general population: a comparative study of clinical, laboratory, and radiological features, severity, and outcome. Virol J. 2021;18(1):243. doi: 10.1186/s12985-021-01713-x, PMID 34876176.
  24. Belsky JA, Tullius BP, Lamb MG, Sayegh R, Stanek JR, Auletta JJ. COVID-19 in immunocompromised patients: a systematic Review of cancer, hematopoietic cell and solid organ transplant patients. J Infectol: Published online. 2021;82(3):329-38. doi: 10.1016/j.jinf.2021.01.022, PMID 33549624.
  25. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin Immunol. Published online; 2020. p. 108427.
  26. Caillard S, Anglicheau D, Matignon M, Durrbach A, Greze C, Frimat L, et al. An initial report from the French SOT COVID Registry suggests high mortality due to Covid-19 in recipients of kidney transplants. Kidney Int. 2020;98(6):1549-58. doi: 10.1016/j.kint.2020.08.005, PMID 32853631.
  27. Chen TY, Farghaly S, Cham S, Tatem LL, Sin JH, Rauda R, et al. COVID?19 pneumonia in kidney transplant recipients: focus on immunosuppression management. Transpl Infect Dis. 2020;22(5):e13378. doi: 10.1111/tid.13378, PMID 32573882.
  28. Hage R, Steinack C, Gautschi F, Schuurmans MM. Transplant drugs against SARS, MERS, and COVID-19. Transplantology. 2020;1(2):71-84. doi: 10.3390/transplantology1020007.
  29. Andersen KM, Mehta HB, Palamuttam N, Ford D, Garibaldi BT, Auwaerter PG, et al. Association between chronic use of immunosuppresive drugs and clinical outcomes from coronavirus disease 2019 (Covid-19) hospitalization: a retrospective cohort study in a large us health system. Clin Infect Dis: Published online. 2021;73(11):e4124-30. doi: 10.1093/cid/ciaa1488, PMID 33410884.
  30. Cravedi P, Mothi SS, Azzi Y, Haverly M, Farouk SS, Pérez-Sáez MJ, et al. COVID-19 and kidney transplantation: results from the TANGO International Transplant Consortium. Am J Transplant. 2020;20(11):3140-8. (PMC Free article). doi: 10.1111/ajt.16185, PMID 32649791, Google Scholar.
  31. Pereira MR, Mohan S, Cohen DJ, Husain SA, Dube GK, Ratner LE, et al. COVID-19 in solid organ transplant recipients: initial report from the US epicenter. Am J Transplant. 2020;20(7):1800-8. (PMC Free article). doi: 10.1111/ajt.15941, PMID 32330343, Google Scholar.
  32. Bossini N, Alberici F, Delbarba E, Valerio F, Manenti C, Possenti S, et al. Kidney transplant patients with SARS-CoV-2 infection: the Brescia Renal COVID task force experience. Am J Transplant. 2020;20(11):3019-29. (PMC Free article). doi: 10.1111/ajt.16176, PMID 32627319.
  33. Kute VB, Bhalla AK, Guleria S, Ray DS, Bahadur MM, Shingare Aet al. Clinical Profile and Outcome of COVID;19 in Clinical Profile and Outcome of COVID-19 in 250 kidney transplant recipients: A multicenter cohort study from India. Transplantation. 2021 Apr 1;105(4):851-60. doi: 10.1097/TP.0000000000003593, PMID 33350674, PMCID PMC7993652.
[Download PDF]
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy
Pharmaceutical Fields
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmaceutics
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Novel drug delivery system
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Nanotechnology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacognosy
© Copyright 2009-2015 IJPBS, India. All rights reserved. Specialized online journals by ubijournal. Website by Ubitech Solutions
         Home I Contact I Terms & Conditions